These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 18519948)

  • 1. Anal cancer: the end of the road for neoadjuvant chemoradiotherapy?
    Glynne-Jones R; Mawdsley S
    J Clin Oncol; 2008 Aug; 26(22):3669-71. PubMed ID: 18519948
    [No Abstract]   [Full Text] [Related]  

  • 2. Commentary: Anal cancer - the benefits of evidence-based treatment.
    Hill J
    Colorectal Dis; 2009 Nov; 11(9):914-6. PubMed ID: 19832863
    [No Abstract]   [Full Text] [Related]  

  • 3. Anal cancer: one step forward--two steps sideways!
    Glynne-Jones R
    Eur J Cancer; 2009 Nov; 45(16):2728-30. PubMed ID: 19762226
    [No Abstract]   [Full Text] [Related]  

  • 4. [Rationale and progress of the phase III trial: intensification of the treatment of locally advanced squamous cell carcinoma of the anal canal].
    Peiffert D
    Cancer Radiother; 2003 Nov; 7 Suppl 1():100s-107s. PubMed ID: 15124551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitomycin-C- or cisplatin-based chemoradiotherapy for anal canal carcinoma: long-term results.
    Olivatto LO; Cabral V; Rosa A; Bezerra M; Santarem E; Fassizoli A; Castro L; Simões JH; Small IA; Ferreira CG
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):490-5. PubMed ID: 20472349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is neoadjuvant chemotherapy prior to radio-chemotherapy beneficial in T4 anal carcinoma?
    Moureau-Zabotto L; Viret F; Giovaninni M; Lelong B; Bories E; Delpero JR; Pesenti C; Caillol F; de Chaisemartin C; Minsat M; Monges G; Sarran A; Resbeut M
    J Surg Oncol; 2011 Jul; 104(1):66-71. PubMed ID: 21240983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current management of anal canal cancer.
    Cummings BJ
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S123-8. PubMed ID: 16399449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.
    Seo Y; Kinsella MT; Reynolds HL; Chipman G; Remick SC; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):143-9. PubMed ID: 19203845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiochemotherapy for locally advanced anal cancer].
    Rödel C
    Onkologie; 2010; 33 Suppl 4():24-5. PubMed ID: 20431309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation therapy for anal cancer.
    Czito BG; Pepek JM; Meyer JJ; Yoo S; Willett CG
    Oncology (Williston Park); 2009 Nov; 23(12):1082-9. PubMed ID: 20017291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining cisplatin and mitomycin with radiotherapy in anal carcinoma.
    Crehange G; Bosset M; Lorchel F; Dumas JL; Buffet-Miny J; Puyraveau M; Mercier M; Bosset JF
    Dis Colon Rectum; 2007 Jan; 50(1):43-9. PubMed ID: 17089083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemoradiotherapy and anal canal cancer].
    Ortholan C; François E; Gérard JP
    Bull Cancer; 2005 Dec; 92(12):1039-47. PubMed ID: 16396750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RTOG 0529: Intensity modulated radiation therapy and anal cancer, a step in the right direction?
    Herman JM; Thomas CR
    Int J Radiat Oncol Biol Phys; 2013 May; 86(1):8-10. PubMed ID: 23582245
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemoradiation therapy for squamous cell carcinoma of anal canal cancer: report of a case.
    Ando H; Nishimura T; Nakamura T; Sugimura H; Nakamura S
    Radiat Med; 2000; 18(3):199-203. PubMed ID: 10972551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adjuvant chemical treatment for bile duct cancer].
    Itoh Y
    Nihon Rinsho; 2006 Jan; 64 Suppl 1():539-42. PubMed ID: 16457321
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of anal cancer in 2010. Part 2: current treatment standards and future directions.
    Abbas A; Yang G; Fakih M
    Oncology (Williston Park); 2010 Apr; 24(5):417-24. PubMed ID: 20480740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Radiochemotherapy in anal carcinoma: radiation plus 5-FU with and without long-term cisplatin infusion].
    Hübener KH
    Strahlenther Onkol; 1993 Nov; 169(11):689-90. PubMed ID: 8248848
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemoradiotherapy of anal cancer is feasible in elderly patients: treatment results of mitomycin-5-FU combined with radiotherapy at Helsinki University Central Hospital 1992-2003.
    Saarilahti K; Arponen P; Vaalavirta L; Tenhunen M; Blomqvist C
    Acta Oncol; 2006; 45(6):736-42. PubMed ID: 16938817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In patients with cancer of the larynx, chemoradiotherapy with cisplatin is superior to neoadjuvant chemotherapy followed by radiotherapy and to exclusive radiotherapy].
    Racadot S; Mazeron JJ
    Bull Cancer; 2004 Mar; 91(3):211-2. PubMed ID: 15171045
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined-modality treatment for anal cancer: current strategies and future directions.
    Fraunholz I; Rabeneck D; Weiss C; Rödel C
    Strahlenther Onkol; 2010 Jul; 186(7):361-6. PubMed ID: 20582392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.